Literature DB >> 1998571

Primary parotid malignancies. A clinical and pathologic review.

W J Kane1, T V McCaffrey, K D Olsen, J E Lewis.   

Abstract

One hundred ninety-four patients with primary malignant tumors of the parotid gland who underwent surgery at the Mayo Clinic (1970 through 1987) are reviewed. Survival patterns were analyzed using the Kaplan-Meier product-limit method that separated histologic results into three significantly different groups. Survival rate was highest for patients with acinic cell, adenoid cystic, and low-grade mucoepidermoid carcinomas; intermediate for patients with high-grade mucoepidermoid carcinomas; and lowest for the remaining six histologic types encountered. Cox multiple linear regression was used to identify patient and tumor characteristics with greatest prognostic significance. In order of decreasing strength, regional metastatic involvement, pain, male gender, grade, stage, and advancing age all demonstrated independent prognostic significance. Fifty-three percent of patients requiring facial nerve sacrifice were asymptomatic at presentation. A high positive correlation was observed between advancing grade and stage.

Entities:  

Mesh:

Year:  1991        PMID: 1998571     DOI: 10.1001/archotol.1991.01870150075010

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  23 in total

1.  Outcomes of temporal bone resection for locally advanced parotid cancer.

Authors:  Saral Mehra; Luc G Morris; Jatin Shah; Mark Bilsky; Samuel Selesnick; Dennis H Kraus
Journal:  Skull Base       Date:  2011-11

2.  Different imaging techniques in the head and neck: Assets and drawbacks.

Authors:  Thomas J Vogl; Marc Harth; Petra Siebenhandl
Journal:  World J Radiol       Date:  2010-06-28

3.  Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor.

Authors:  Shogo Matsuda; Hiroyoshi Iguchi; Takuhito Tada; Masako Hosono; Masahiko Osawa; Yuuko Kuwae; Hideyuki Morimoto; Eiichiro Okazaki; Kosuke Amano; Yoshitaka Miki; Shinichi Tsutsumi; Yasuhiko Shimatani; Yukio Miki
Journal:  Jpn J Radiol       Date:  2015-07-10       Impact factor: 2.374

4.  Salivary Duct Carcinoma of Parotid Gland: a Rare Tumor.

Authors:  Giridhar Chidananda-Murthy; Jayanthi Chandran
Journal:  Indian J Surg Oncol       Date:  2018-12-12

Review 5.  [Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-09       Impact factor: 1.284

6.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

7.  Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors.

Authors:  Guevara-Canales Janet-Ofelia; Morales-Vadillo Rafael; Guzmán-Arias Guillermo; Cava-Vergiú Carlos-Enrique; Robello-Malatto José-Martín; Guerra-Miller Henry; Montes-Gil Jaime-Enrique
Journal:  J Maxillofac Oral Surg       Date:  2016-07-29

8.  Acinic cell carcinoma in pregnancy: a case report and review of the literature.

Authors:  Nabil N Al-Zaher; Amani A Obeid
Journal:  J Med Case Rep       Date:  2011-03-04

9.  Increased local recurrence in advanced parotid malignancy treated with mastoidectomy without lateral temporal bone resection.

Authors:  Sameep Kadakia; David Chan; Yadranko Ducic; Ricardo Cristobal; Moustafa Mourad
Journal:  Oral Maxillofac Surg       Date:  2016-09-30

10.  Oncological outcomes of preoperatively unexpected malignant tumors of the parotid gland.

Authors:  Hanaro Park; Sungjun Han; Sung Joon Park; Young Ho Jung; Soon-Hyun Ahn; Woo-Jin Jeong
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.